Pharmaceuticals – Analytical and Bioanalytical

Expert guidance for reliable study outcomes

Strategic support from method development to the interpretation of pharmacokinetic data in animal and human studies.

CRONET offers specialised consulting for analytical and bioanalytical activities, guiding pharmaceutical and biotech companies in the planning, coordination and interpretation of key studies in all phases of development. We collaborate closely with CROs and analytical laboratories  to ensure that methods and data meet scientific and regulatory standards.

From Method Development to Formulation Strategy

We support our clients in defining and reviewing strategies for the development of analytical methods and ensure that such methods are in line with regulatory expectations.

Support for PK and TK Study Design & Review

CRONET provides expert advice on pharmacokinetic (PK) study design, sampling strategies and data interpretation to support early and late-stage development.
We also provide advice on toxicokinetic (TK) studies, helping clients align exposure data with toxicological findings and regulatory expectations to meet both GLP and non-GLP requirements.

Advantages for customers:

  • Strategic planning of studies with a regulatory and scientific focus
  • Support in the selection and coordination of the most suitable CROs

  • Independent interpretation of analytical, PK and TK data

  • Quality monitoring to avoid delays or rework when submitting marketing authorisation applications

  • Customised advice for the development of human medicinal products

Why Choose CRONET?

Completeness

All your preclinical needs covered in one place

Expert Guidance

A team of dedicated experts focused on your success

Innovation

Access to cutting-edge techniques and multidisciplinary services

Efficiency

Optimized costs, timelines, and study quality

Contact us

    I declare that I have read the Privacy Policy and I consent to the processing of my personal data.